In 2026, these oral GLP-1 medications are gaining attention for their simplified dosing and improved convenience
was funded by the Deutsche Forschungsgemeinschaft (SFB/Transregio 166Project C1) and a Wellcome Trust Senior Research Fellowship
The mitochondrial impairment in FM is evident from reduced bioenergetic health index (BHI) and increased mitochondrial miRNAs (mitomiR-145-5p) in peripheral blood mononuclear cells (PBMCs), which regulate oxidative stress responses ( Observational studies indeed suggest that oxidative stress disrupts neurotransmitter regulation, particularly serotonin ( Lipid metabolism alterations and fibromyalgia Recent metabolomic studies have highlighted significant alterations in lipid metabolism in FM patients, particularly shifts in phospholipid composition ( Notably, LPC (16:0), a lipid oxidation product, is elevated in FM and directly activates acid-sensing ion channel 3 (ASIC3) on nociceptors, leading to hyperalgesia in animal models ( Antioxidant defense impairment in fibromyalgia The imbalance between ROS production and antioxidant defenses is a feature of FM pathophysiology ( Several studies have shown that antioxidant enzyme deficiencies, including low SOD, glutathione peroxidase, and catalase, correlate inversely with disease severity measures such as the Fibromyalgia Impact Questionnaire (FIQR), pain scores, and anxiety levels ( Further, the nuclear factor erythroid 2-related factor 2 (NRF2) pathway is a master regulator of antioxidant and cytoprotective gene expression, crucial for cellular defense against oxidative stress
Results develop gradually and vary based on the specific peptides used, dosage, and individual response
